Bellevue, WA, United States of America

Arthur H Goldkamp


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arthur H. Goldkamp

Introduction: Arthur H. Goldkamp is a notable inventor based in Bellevue, WA, who has made significant advancements in the field of biochemistry and pharmaceuticals. With a total of two patents to his name, his work primarily focuses on compounds with potential sweetening and pharmacological applications.

Latest Patents: Goldkamp’s latest patents include the invention of 3-Amino-N-substituted succinamic acids, which are synthesized by coupling a protected L-aspartic acid derivative with the appropriate amine and subsequently cleaving the protecting groups. These compounds serve as potent sweetening agents and display remarkable pharmacological properties, including anti-inflammatory effects. His second patent, titled 3-Amino-N-substituted succinamic acids and intermediates thereto, echoes the innovative processes and benefits outlined in his first patent.

Career Highlights: Goldkamp has dedicated a significant portion of his career to research and development in the pharmaceutical industry. He is affiliated with G.D. Searle & Company, where he has contributed to various projects that lead to the development of innovative medicinal compounds.

Collaborations: Throughout his career, Goldkamp has collaborated with esteemed colleagues, including Robert H. Mazur and James M. Schlatter. Their combined expertise and efforts have fostered a creative environment conducive to pioneering research and development in their respective fields.

Conclusion: Arthur H. Goldkamp stands out as an influential inventor whose contributions have not only pushed the boundaries of scientific knowledge but have also provided practical applications in medicine. With his innovative spirit, he continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…